149 related articles for article (PubMed ID: 27588117)
1. Survivin and gliomas: A literature review.
Varughese RK; Torp SH
Oncol Lett; 2016 Sep; 12(3):1679-1686. PubMed ID: 27588117
[TBL] [Abstract][Full Text] [Related]
2. Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
Zhen HN; Zhang X; Hu PZ; Yang TT; Fei Z; Zhang JN; Fu LA; He XS; Ma FC; Wang XL
Cancer; 2005 Dec; 104(12):2775-83. PubMed ID: 16284993
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in Survivin (
Sušac I; Ozretić P; Gregorić M; Levačić Cvok M; Sabol M; Levanat S; Trnski D; Eljuga D; Seiwerth S; Aralica G; Stanec M; Musani V
J Oncol; 2019; 2019():3483192. PubMed ID: 31467536
[TBL] [Abstract][Full Text] [Related]
4. Association between functional variants in BIRC5/survivin gene 3' untranslated region and mRNA expression in lymphoblastoid cell lines.
Pu F; Shao Z; Yang S; Liu J; Lin S; Ma X; Yang H
Oncol Lett; 2015 Oct; 10(4):2319-2322. PubMed ID: 26622842
[TBL] [Abstract][Full Text] [Related]
5. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
Span PN; Tjan-Heijnen VC; Heuvel JJ; de Kok JB; Foekens JA; Sweep FC
Clin Chem; 2006 Sep; 52(9):1693-700. PubMed ID: 16873289
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
Uematsu M; Ohsawa I; Aokage T; Nishimaki K; Matsumoto K; Takahashi H; Asoh S; Teramoto A; Ohta S
J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
[TBL] [Abstract][Full Text] [Related]
7. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
Sasaki T; Lopes MB; Hankins GR; Helm GA
Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
[TBL] [Abstract][Full Text] [Related]
8. Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker.
Bodey B; Bodey V; Siegel SE; Kaiser HE
In Vivo; 2004; 18(6):713-8. PubMed ID: 15646811
[TBL] [Abstract][Full Text] [Related]
9. What is the impact of BIRC5 gene polymorphisms on urinary cancer susceptibility? Evidence from 9348 subjects.
Xu M; Hu X; Zhang M; Ge Y
Gene; 2020 Apr; 733():144268. PubMed ID: 31809840
[TBL] [Abstract][Full Text] [Related]
10. The role of survivin as a new target of diagnosis and treatment in human cancer.
Yamamoto T; Tanigawa N
Med Electron Microsc; 2001 Dec; 34(4):207-12. PubMed ID: 11956993
[TBL] [Abstract][Full Text] [Related]
11. Survivin expression in glioblastomas correlates with proliferation, but not with apoptosis.
Mellai M; Caldera V; Patrucco A; Annovazzi L; Schiffer D
Anticancer Res; 2008; 28(1A):109-18. PubMed ID: 18383832
[TBL] [Abstract][Full Text] [Related]
12. Survivin as a novel target protein for reducing the proliferation of cancer cells.
Li D; Hu C; Li H
Biomed Rep; 2018 May; 8(5):399-406. PubMed ID: 29725522
[TBL] [Abstract][Full Text] [Related]
13. Potential Involvement of
Gil-Kulik P; Krzyżanowski A; Dudzińska E; Karwat J; Chomik P; Świstowska M; Kondracka A; Kwaśniewska A; Cioch M; Jojczuk M; Nogalski A; Kocki J
Oxid Med Cell Longev; 2019; 2019():8727925. PubMed ID: 30774747
[TBL] [Abstract][Full Text] [Related]
14. [Expression of the antiapoptotic protein survinin and its gene in primary breast carcinoma].
Shlyakhtunov YA; Klopova VA
Arkh Patol; 2019; 81(2):18-23. PubMed ID: 31006775
[TBL] [Abstract][Full Text] [Related]
15. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors.
Söling A; Plugge EM; Schmitz M; Weigle B; Jacob R; Illert J; Holzhausen HJ; Rainov NG
Int J Oncol; 2007 Jan; 30(1):123-8. PubMed ID: 17143520
[TBL] [Abstract][Full Text] [Related]
17. Expression of p16 and Survivin in gliomas and their correlation with cell proliferation.
Gao Y; Li L; Song L
Oncol Lett; 2015 Jul; 10(1):301-306. PubMed ID: 26171019
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas.
Varughese RK; Skjulsvik AJ; Torp SH
Pathol Res Pract; 2017 Apr; 213(4):339-347. PubMed ID: 28214203
[TBL] [Abstract][Full Text] [Related]
19. Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades.
Lebelt A; Rutkowski R; Och W; Jaczun K; Dziemiańczyk-Pakieła D; Milewski R; Mariak Z; Reszeć J
Adv Med Sci; 2016 Sep; 61(2):237-243. PubMed ID: 26995334
[TBL] [Abstract][Full Text] [Related]
20. Proteome analysis of a hepatocyte-specific BIRC5 (survivin)-knockout mouse model during liver regeneration.
Bracht T; Hagemann S; Loscha M; Megger DA; Padden J; Eisenacher M; Kuhlmann K; Meyer HE; Baba HA; Sitek B
J Proteome Res; 2014 Jun; 13(6):2771-82. PubMed ID: 24818710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
